Teva announces new data from women's health franchise

Teva Women's Health today announced new data from the Company's expanding women's health franchise will be featured at the 60th Annual Clinical Meeting of the American Congress of Obstetricians and Gynecologists (ACOG) in San Diego, California, May 5-9, 2012.  Featured presentations and abstracts will include new data on Plan B One-Step® (levonorgestrel) tablet 1.5mg, the only one pill emergency contraceptive available over-the-counter to women 17 years of age and older, and results from the Phase II study evaluating oxybutynin vaginal ring for women with overactive bladder.

Prescription required for women under age 17.

Featured presentations include:

• An assessment of young adolescents' ability to understand the key concepts needed for safe and effective over-the-counter use of emergency contraceptives
• An analysis of the effects of two doses of oxybutynin delivered by a monthly vaginal ring compared to placebo on Urogenital Distress Inventory (UDI) outcomes in women with overactive bladder

Platform Presentation/Poster Session Details:

Plan B One-Step®

• [P918] Can Young Adolescents Use Emergency Contraception Over-the-Counter? (Poster Session 1: Contraception/Family Planning – Number 10: Monday, May 7, 2012, 3:00-4:00 p.m. PDT) Tina R. Raine-Bennett, Oakland, CA; Nancy Ricciotti, MSN, North Wales, PA; Abby Sokoloff, MPH, San Francisco, CA

Oxybutynin Vaginal Ring

• [P353] Evaluation of the Urogenital Distress Inventory in Users of a Monthly Oxybutynin Vaginal Ring (Poster Session 1: Urogynecology – Number 100: Monday, May 7, 2012, 3:00-4:00 p.m. PDT) Bruce J. Levine, Moorestown, NJ; Kathleen Z. Reape; Sally M. Fedon, North Wales, PA

"We are pleased to contribute to the scientific exchange that makes the annual ACOG meeting such an important event for the thousands of physicians who have dedicated their careers to caring for the unique and diverse needs of women of all ages," said Nancy Ricciotti, Senior Director, Teva Women's Health R&D. "With our heritage in innovative reproductive health products and our current focus on evolving our business to meet the needs of the patient and provider communities, we are committed to continuing to evolve our specialized branded pharmaceutical franchises, of which women's health is a strong focus."